TABLE 3.
TLS density and maturity in different groups
| TLS density(p value) | TLS maturity (Grade I II III) (p value) | |
|---|---|---|
| Sex(F/M) | 0.458 ± 0.09/0.351 ± 0.08(0.0545) | 91–41‐87/55–17‐7 (0.360) |
| Age(60+/60‐) | 0.335 ± 0.05/0.528 ± 0.132(0.0336) | 78–36‐9/68–22‐6 (0.508) |
| Smoking(Y/N) | 0.442 ± 0.16/0.418 ± 0.07(0.6179) | 19–8‐6/123–50‐9 (0.051) |
| EGFR mutation(Y/N) | 0.415 ± 0.06/0.434 ± 0.32(0.0598) | 115–52‐13/31–6‐2 (0.218) |
| Pathological types | ||
| MIA/AIS | 0.443 ± 0.28/0.216 ± 0.23(0.6343) | 27–5‐2/3–1‐0 (0.629) |
| IAC/AIS | 0.420 ± 0.06/0.216 ± 0.23(0.2694) | 116–52‐13/3–1‐0 (1.000) |
| MIA/IAC | 0.443 ± 0.28/0.420 ± 0.06(0.1346) | 27–5‐2/116–52‐13 (0.213) |
| CT features | ||
| pGGN/mGGN | 0.178 ± 0.06/0.522 ± 0.12(0.0001) | 26–7‐1/67–28‐9 (0.397) |
| pGGN/SN | 0.178 ± 0.06/0.388 ± 0.08(0.0003) | 26–7‐1/53–23‐5 (0.587) |
| mGGN/SN | 0.522 ± 0.12/0.388 ± 0.08(0.0526) | 67–28‐9/53–23‐5 (0.813) |
| Tumor stages | 0.183 | 0.026 |
| IA1‐IA3 | 0.399 ± 0.03 | 130–45‐14 |
| IB‐IIB | 0.533 ± 0.14 | 15–13‐1 |
p < 0.05 was considered significant.
Abbreviations: AIS, adenocarcinoma in situ; MIA, minimally invasive adenocarcinoma; IAC, invasive adenocarcinoma; pGGN, pure ground‐glass nodule; PSN, part‐solid nodule; SN, solid nodule.